Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-06-08 to 2023-06-09
Current total value of award: $627.14
Description: 4561180755!QUILLIVANT XR ORAL SUSP 120ML 5MG/ML